Please provide your email address to receive an email when new articles are posted on . Patients who started adjuvant chemotherapy more than 6 weeks after colorectal cancer surgery achieved poorer DFS ...

Adjuvant Chemotherapy after Surgery in Stage II and III Colon Cancer: The Sooner the Better? In surgically resectable disease, adjuvant chemotherapy has been clearly demonstrated to increase the ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient DNA mismatch repair (dMMR) colon cancer significantly improved survival in ...

SAN FRANCISCO -- Circulating tumor DNA (ctDNA) measurements showed promise for identifying patients with early colorectal cancer (CRC) most likely to benefit from adjuvant therapy, analyses of two ...

Data support routine use of circulating tumor DNA testing in management of stage III colon cancer patients Tumor fraction analysis provides further insights for patient management in patients with ...

Individual medical records of 580 patients with CC who initiated AC August 2005-November 2010 at two large academic cancer centers in Eastern Ontario were reviewed. Information regarding patient, ...

In March 2024, Catherine, the Princess of Wales, announced her cancer diagnosis. The 42-year-old did not reveal the type of cancer she was facing but shared that she had undergone major abdominal ...

Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant treatment for colon cancer. The oral fluoropyrimidine capecitabine is an established alternative to bolus fluorouracil plus ...

Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...